Skip to main content
Sign In

University of Colorado Denver Hematology, Blood Cancer, Bone Marrow Transplant Program News

 Blood Cancer, Bone Marrow Transplant Program Logo


News and Highlights from the Blood Cancer and BMT Program

Daniel Pollyea, MD Selected as Outstanding Early Career Scholar

Daniel Pollyea, MD

Dr. Pollyea will utilize funding from this award to develop a program to systematically test leukemia stem-cell directed therapies.

Make sure you’re in the know!

The Bloodline

Sign up for our patient focused digital newsletter, The Bloodline, which is published quarterly. The newsletter includes tips for patients, articles on self-care, a dietician approved recipe and information on what’s going on with our program.

Mentors Aren’t Just for Business Anymore

Imerman Angels

A new program at the University of Colorado Cancer Center provides individual mentoring to patients and caregivers to provide additional support through the cancer journey. Meet Kaitlyn Cavanaugh, the Imerman Angels Program Ambassador for Colorado.

Moms in Training

Moms in Training

Join a group of moms training to run or walk a 10K or half marathon while raising money to help find a cure for blood cancers.

Cancer Support Groups

Cancer Support Groups

Find information about Cancer Support Groups in Colorado.

Behind the Scrubs: Sarah Strozinski

From her favorite part about her job to her favorite movie, our “Behind the Scrubs” interview with our new Post-Transplant Survivorship coordinator gives you a chance to get to know a little about Sarah Strozinski, RN, BSN, OCN and her role on our team.

How "SMART" are your Goals?


Research tells us that when implementing any new goal for yourself, it is helpful to make your goal specific, obtainable, manageable, and relevant to you. You may be asking yourself “How do I go about making, and specifying, a goal for myself?”

Professor Doug Graham Publishes Leading Article on New Cancer Therapies

In the featured article in the December issue of Nature Reviews Cancer, Dr. Graham describes the emerging field of TAM family kinases and their potential as therapeutic targets in leukemia and other forms of cancer.

Dr. Daniel Pollyea Reports the Latest Results from a New Leukemia Drug

Speaking at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, Dr. Pollyea summarized the latest results for AG-120, an exciting new drug for the treatment of patients with advanced leukemia.

Rachel Rabinovitch Represents CU Cancer Center in Jerusalem and Tel Aviv

Israel has the highest BRCA+ prevalence of any nation. Rabinovitch will deliver lectures and collaborate with health professionals who have expertise with the BRCA+ population in Israel.

Welcome Dr. Manali Kamdar

We are very pleased to announce that Dr. Manali Kamdar will be joining us in late November as a new attending physician and Assistant Professor in the Division of Hematology.

Benjamin Brewer Awarded NCCN Grant

"If patients are having difficulties taking their medications, I want to provide the physicians with strategies to help their patients stay on schedule," says Brewer.

Nurse Navigators Help Patients Find Needed Care

Read how the Blood Cancer program's Christine Frodella and other nurse navigators support patients at the University of Colorado Cancer Center

Experimental Drugs Approved Faster

81-year-old Larry Rosenberg credits an experimental drug with saving his life from chronic lymphocytic leukemia. Now the Break Through Therapy Provision will help other patients get faster access to experimental drugs as well.

KCBO Radio Interview with Emily

KCBO radio interview with our patient Emily about her experience with blood cancer. Her doctors treated her for an aggressive form of leukemia.